These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17091190)

  • 1. Effects of raloxifene on caveolin-1 mRNA and protein expressions in vascular smooth muscle cells.
    Yang FL; He H; Liu XX; Tu B; Zeng XW; Su JX; Wang X; Hu Q
    Acta Biochim Biophys Sin (Shanghai); 2006 Nov; 38(11):747-52. PubMed ID: 17091190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells.
    Takahashi K; Ohmichi M; Yoshida M; Hisamoto K; Mabuchi S; Arimoto-Ishida E; Mori A; Tsutsumi S; Tasaka K; Murata Y; Kurachi H
    J Endocrinol; 2003 Aug; 178(2):319-29. PubMed ID: 12904179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-κB-dependent CCL20 expression in reactive astrocytes.
    Li R; Xu W; Chen Y; Qiu W; Shu Y; Wu A; Dai Y; Bao J; Lu Z; Hu X
    PLoS One; 2014; 9(4):e94320. PubMed ID: 24722370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-independent relaxation to raloxifene in porcine coronary artery.
    Leung HS; Seto SW; Kwan YW; Leung FP; Au AL; Yung LM; Yao X; Huang Y
    Eur J Pharmacol; 2007 Jan; 555(2-3):178-84. PubMed ID: 17113071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selective estrogen receptor modulator raloxifene plus 17-beta estradiol in aorta and mammary gland of female experimental atherosclerosis rabbits and possible involvement of ERK signal transduction pathway.
    Xiang QL; Chen Y; Lin GP; Tan Z; Wang TH
    Chin J Physiol; 2006 Jun; 49(3):132-40. PubMed ID: 16970244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal effects of 17beta-estradiol on caveolin-1 mRNA and protein in bovine aortic endothelial cells.
    Jayachandran M; Hayashi T; Sumi D; Iguchi A; Miller VM
    Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H1327-33. PubMed ID: 11514304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raloxifene elicits combined rapid vasorelaxation and long-term anti-inflammatory actions in rat aorta.
    Pinna C; Bolego C; Sanvito P; Pelosi V; Baetta R; Corsini A; Gaion RM; Cignarella A
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1444-51. PubMed ID: 16943257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Selective Estrogen Receptor Modulator Raloxifene Regulates Arginine-Vasopressin Gene Expression in Human Female Neuroblastoma Cells Through G Protein-Coupled Estrogen Receptor and ERK Signaling.
    Grassi D; Ghorbanpoor S; Acaz-Fonseca E; Ruiz-Palmero I; Garcia-Segura LM
    Endocrinology; 2015 Oct; 156(10):3706-16. PubMed ID: 26200092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective estrogen receptor modulators prevent neointima formation after vascular injury.
    Savolainen-Peltonen H; Luoto NM; Kangas L; Häyry P
    Mol Cell Endocrinol; 2004 Nov; 227(1-2):9-20. PubMed ID: 15501580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1.
    Dahm AE; Iversen N; Birkenes B; Ree AH; Sandset PM
    BMC Cardiovasc Disord; 2006 Oct; 6():40. PubMed ID: 17029634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of acute and repeated exposure to raloxifene in ovariectomized sheep.
    Zoma WD; Baker RS; Mershon JL; Clark KE
    Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1216-25. PubMed ID: 16517945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene analogue LY117018 suppresses oxidative stress-induced endothelial cell apoptosis through activation of ERK1/2 signaling pathway.
    Yu J; Eto M; Kozaki K; Akishita M; Okabe T; Ouchi Y
    Eur J Pharmacol; 2008 Jul; 589(1-3):32-6. PubMed ID: 18541231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol regulates monocyte chemotactic protein-1 in human coronary artery smooth muscle cells: a mechanism for its antiatherogenic effect.
    Seli E; Selam B; Mor G; Kayisli UA; Pehlivan T; Arici A
    Menopause; 2001; 8(4):296-301. PubMed ID: 11449089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of the divergent effects of estrogen on the cell proliferation of human umbilical endothelial versus aortic smooth muscle cells.
    Kawagoe J; Ohmichi M; Tsutsumi S; Ohta T; Takahashi K; Kurachi H
    Endocrinology; 2007 Dec; 148(12):6092-9. PubMed ID: 17872375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease.
    O'Neill K; Chen S; Brinton RD
    Exp Neurol; 2004 Jan; 185(1):63-80. PubMed ID: 14697319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressions of vascular endothelial growth factor and nitric oxide synthase III in the thyroid gland of ovariectomized rats are upregulated by estrogen and selective estrogen receptor modulators.
    de Araujo LF; Grozovsky R; dos Santos Pereira MJ; de Carvalho JJ; Vaisman M; Carvalho DP
    Thyroid; 2010 Jan; 20(1):85-92. PubMed ID: 20017619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat.
    Pinilla L; Barreiro ML; Gonzalez LC; Tena-Sempere M; Aguilar E
    J Endocrinol; 2002 Mar; 172(3):441-8. PubMed ID: 11874692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques.
    Bethea CL; Mirkes SJ; Su A; Michelson D
    Psychoneuroendocrinology; 2002 May; 27(4):431-45. PubMed ID: 11911997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.
    Bellosta S; Baetta R; Canavesi M; Comparato C; Granata A; Monetti M; Cairoli F; Eberini I; Puglisi L; Corsini A
    Pharmacol Res; 2007 Aug; 56(2):160-7. PubMed ID: 17582780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutically relevant concentrations of raloxifene dilate pressurized rat resistance arteries via calcium-dependent endothelial nitric oxide synthase activation.
    Chan YC; Leung FP; Wong WT; Tian XY; Yung LM; Lau CW; Tsang SY; Yao X; Chen ZY; Huang Y
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):992-9. PubMed ID: 20185791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.